# FDA Approves Generic Difluprednate Ophthalmic from Alembic Pharmaceuticals The FDA has approved Alembic Pharmaceuticals' generic difluprednate opht...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Novitium Pharma secured FDA approval for its ANDA 219119, a milestone anticipated to accelerate revenue generation and strengthen the company's compet...
On January 21, 2026, the FDA approved AVTOZMA (tocilizumab) for subcutaneous administration, marking an expansion of Celltrion USA, Inc.’s portfolio a...
Camber Pharmaceuticals, Inc. received final FDA approval on January 21, 2026, for its buccal buprenorphine and naloxone tablets, slated to compete aga...
# FDA Approves Novo Nordisk's Oral Semaglutide (Wegovy) Novo Nordisk Pharmaceutical Industries, LP received FDA approval for the oral formulation of ...
Following the FDA approval of Camber Pharmaceuticals' and the BioSignia Partners-managed consortium's ANDA for Meloxifene tablets on December 18, the ...
Camber Pharmaceuticals, Inc. received FDA approval for its Abbreviated New Drug Application (ANDA219727) for the sublingual formulation of buprenorphi...
LIB Therapeutics, Inc. has received FDA approval for LEROCHOL (lerodalcibep), a novel injection scheduled to launch on December 12, 2025, marking the ...
On December 10, 2025, SpecGx LLC received FDA approval for the generic sublingual tablet formulation of Buprenorphine Hydrochloride (ANDA 218473), a s...
# FDA Approves Generic MACITENTAN from Novugen Pharma The FDA has approved Novugen Pharma's generic version of MACITENTAN, an endothelin receptor ant...
Bayer HealthCare Pharmaceuticals Inc. secured FDA approval for HYRNUO (sevabertinib), an oral anticancer agent indicated for advanced system mastocyto...
# FDA Approves Generic Lenalidomide from Accord Healthcare Inc. Accord Healthcare Inc. received FDA approval for generic lenalidomide (ANDA218872), m...
# FDA Approves PAI Pharma's Generic Voriconazole Injection PAI Holdings, LLC dba PAI Pharma received FDA approval for its generic voriconazole intrav...
# FDA Approves Generic Leuprolide Acetate from Zydus Pharmaceuticals Zydus Pharmaceuticals USA Inc. received FDA approval for generic leuprolide acet...
Amneal Pharmaceuticals Private Limited secured FDA approval for its intra-articular formulation of IOHEXOL, positioning the drugmaker to capture marke...
NOVAST LABS has secured FDA approval for a new generic drug, according to ANDA 218031, a move expected to immediately impact market pricing dynamics f...
Boehringer Ingelheim Pharmaceuticals, Inc. has received FDA approval for the oral prescription drug NERANDOMILAST (NDA218764), branded as JASCAYD. Thi...
Northeast Ohio-based CELLTRION INC. announced today that the U.S. FDA granted approval for a substantial new entity, triggering a significant market o...
Merck is slated to launch KEYTRUDA QLEX, a novel subcutaneous formulation of pembrolizumab, on September 19, 2025, anticipating a shift in market dyna...
# FDA Approves Lupin's Generic Drug Application Lupin Limited received FDA approval for its abbreviated new drug application (ANDA 214398) on Septemb...